These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 27003600)

  • 1. Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.
    Nobili V; Alisi A; Newton KP; Schwimmer JB
    Gastroenterology; 2016 Jun; 150(8):1798-810. PubMed ID: 27003600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
    Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
    Zhu C; Zhou D; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease.
    Goyal NP; Schwimmer JB
    Clin Liver Dis; 2016 May; 20(2):325-38. PubMed ID: 27063272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research advances in the impact of nonalcoholic fatty liver disease on cardiac structure and function].
    Gu LF; Wang YQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):461-4. PubMed ID: 27465954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030.
    Alswat K; Aljumah AA; Sanai FM; Abaalkhail F; Alghamdi M; Al Hamoudi WK; Al Khathlan A; Al Quraishi H; Al Rifai A; Al Zaabi M; Babatin MA; Estes C; Hashim A; Razavi H
    Saudi J Gastroenterol; 2018; 24(4):211-219. PubMed ID: 29956688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease and cardiovascular disease.
    Hyogo H; Chayama K; Yamagishi S
    Curr Pharm Des; 2014; 20(14):2403-11. PubMed ID: 23844815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation of risk factors between metabolic syndrome and nonalcoholic fatty liver disease in children and adolescents].
    Smolka V; Ehrmann J; Tkachyk O; Zápalka M
    Cas Lek Cesk; 2014; 153(2):91-7. PubMed ID: 24797780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease in Children.
    Mann JP; Valenti L; Scorletti E; Byrne CD; Nobili V
    Semin Liver Dis; 2018 Feb; 38(1):1-13. PubMed ID: 29471561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Nonalcoholic Fatty Liver Disease in New York City: An Autopsy Study.
    Fernandes DM; Pantangi V; Azam M; Salomao M; Iuga AC; Lefkowitch JH; Gill J; Morotti R; Lavine JE; Mencin AA
    J Pediatr; 2018 Sep; 200():174-180. PubMed ID: 29903531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease: Evolving paradigms.
    Lonardo A; Nascimbeni F; Maurantonio M; Marrazzo A; Rinaldi L; Adinolfi LE
    World J Gastroenterol; 2017 Sep; 23(36):6571-6592. PubMed ID: 29085206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
    Kim D; Touros A; Kim WR
    Clin Liver Dis; 2018 Feb; 22(1):133-140. PubMed ID: 29128053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis.
    Ratziu V; Ghabril M; Romero-Gomez M; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):28-38. PubMed ID: 30300289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
    Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
    World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study.
    Allen AM; Therneau TM; Larson JJ; Coward A; Somers VK; Kamath PS
    Hepatology; 2018 May; 67(5):1726-1736. PubMed ID: 28941364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name.
    Ng CH; Huang DQ; Nguyen MH
    Clin Mol Hepatol; 2022 Oct; 28(4):790-801. PubMed ID: 35545437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.